cAMP controls the restoration of endothelial barrier function after thrombin-induced hyperpermeability via Rac1 activation
Open Access
- 24 October 2014
- journal article
- research article
- Published by Wiley in Physiological Reports
- Vol. 2 (10) , e12175
Abstract
Inflammatory mediators like thrombin disrupt endothelial adherens junctions (AJs) and barrier integrity leading to oedema formation followed by resealing of AJs and a slow recovery of the barrier function. The molecular mechanisms of this process have not yet been fully delineated. The aim of the present study was to analyse the molecular mechanism of endothelial barrier recovery and thrombin was used as model inflammatory mediator. Thrombin caused a strong increase in endothelial permeability within 10 min accompanied by loss of Rac1 but not cdc42 activity, drop in cellular cAMP contents, and a strong activation of the endothelial contractile machinery mainly via RhoA/Rock signalling. Activation of RhoA/Rock signalling precedes and is dependent upon a rise in the cytosolic Ca2+ concentration. Inhibition of cytosolic Ca2+ rise but not MLCK or Rock enhances the recovery of endothelial barrier function. The cellular cAMP contents increased gradually during the barrier recovery phase (30–60 min after thrombin challenge) accompanied by an increase in Rac1 activity. Inhibition of Rac1 activity using a specific pharmacological inhibitor (NSC23766) abrogated the endothelial barrier recovery process, suggesting a Rac1‐dependent phenomenon. Likewise, inhibition of either adenylyl cyclase or the cAMP‐effectors PKA and Epac (with PKI and ESI‐09, respectively) caused an abrogation of Rac1 activation, resealing of endothelial AJs and recovery of endothelial barrier function. The data demonstrate that endothelial barrier recovery after thrombin challenge is regulated by Rac1 GTPase activation. This Rac1 activation is due to increased levels of cellular cAMP and activation of downstream signalling during the barrier recovery phase.Keywords
Funding Information
- University of Giessen Anschubfinanzierung
This publication has 31 references indexed in Scilit:
- Rap-afadin axis in control of Rho signaling and endothelial barrier recoveryMolecular Biology of the Cell, 2013
- A Novel EPAC-Specific Inhibitor Suppresses Pancreatic Cancer Cell Migration and InvasionMolecular Pharmacology, 2013
- Intermedin (adrenomedullin2) stabilizes the endothelial barrier and antagonizes thrombin‐induced barrier failure in endothelial cell monolayersBritish Journal of Pharmacology, 2011
- Beta-Adrenergic Stimulation Contributes to Maintenance of Endothelial Barrier Functions Under Baseline ConditionsMicrocirculation, 2011
- Temporally resolved cAMP monitoring in endothelial cells uncovers a thrombin‐induced [cAMP] elevation mediated via the Ca2+‐dependent production of prostacyclinThe Journal of Physiology, 2010
- Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMPMicrovascular Research, 2010
- Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeabilityAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- The role of adherens junctions and VE-cadherin in the control of vascular permeabilityJournal of Cell Science, 2008
- Epac/Rap and PKA are novel mechanisms of ANP‐induced Rac‐mediated pulmonary endothelial barrier protectionJournal of Cellular Physiology, 2007
- Adenylyl Cyclase 6 Overexpression Decreases the Permeability of Endothelial Monolayers via Preferential Enhancement of Prostacyclin Receptor FunctionMolecular Pharmacology, 2006